State Street’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-158,852
| Closed | -$642K | – | 4273 |
|
|
2025
Q1 | $642K | Buy |
158,852
+10,300
| +7% | +$34.3K | ﹤0.01% | 3533 |
|
|
2024
Q4 | $475K | Buy |
148,552
+54,128
| +57% | +$184K | ﹤0.01% | 3630 |
|
|
2024
Q3 | $212K | Buy |
94,424
+23,000
| +32% | +$53.1K | ﹤0.01% | 3813 |
|
|
2024
Q2 | $154K | Buy |
71,424
+10,900
| +18% | +$19.4K | ﹤0.01% | 3888 |
|
|
2024
Q1 | $124K | Hold |
60,524
| – | – | ﹤0.01% | 3990 |
|
|
2023
Q4 | $139K | Buy |
60,524
+24,400
| +68% | +$53.1K | ﹤0.01% | 3977 |
|
|
2023
Q3 | $61.4K | Buy |
36,124
+8,677
| +32% | +$19.7K | ﹤0.01% | 4234 |
|
|
2023
Q2 | $67.8K | Sell |
27,447
-158
| -0.6% | -$432 | ﹤0.01% | 4327 |
|
|
2023
Q1 | $62.1K | Buy |
27,605
+8,798
| +47% | +$44.2K | ﹤0.01% | 4451 |
|
|
2022
Q4 | $96.1K | Sell |
18,807
-1,911
| -9% | -$13.8K | ﹤0.01% | 4380 |
|
|
2022
Q3 | $215K | Hold |
20,718
| – | – | ﹤0.01% | 4109 |
|
|
2022
Q2 | $213K | Sell |
20,718
-376
| -2% | -$4.92K | ﹤0.01% | 4168 |
|
|
2022
Q1 | $373K | Buy |
21,094
+1,847
| +10% | +$39.7K | ﹤0.01% | 4163 |
|
|
2021
Q4 | $599K | Hold |
19,247
| – | – | ﹤0.01% | 3955 |
|
|
2021
Q3 | $635K | Hold |
19,247
| – | – | ﹤0.01% | 3895 |
|
|
2021
Q2 | $568K | Sell |
19,247
-66,052
| -77% | -$1.83M | ﹤0.01% | 3809 |
|
|
2021
Q1 | $2.68M | Buy |
85,299
+7,220
| +9% | +$242K | ﹤0.01% | 3316 |
|
|
2020
Q4 | $2.07M | Buy |
78,079
+11,585
| +17% | +$293K | ﹤0.01% | 3365 |
|
|
2020
Q3 | $1.78M | Buy |
66,494
+7,876
| +13% | +$189K | ﹤0.01% | 3242 |
|
|
2020
Q2 | $1.16M | Buy |
58,618
+6,942
| +13% | +$126K | ﹤0.01% | 3379 |
|
|
2020
Q1 | $780K | Buy |
51,676
+2,735
| +6% | +$48.4K | ﹤0.01% | 3363 |
|
|
2019
Q4 | $842K | Buy |
48,941
+15,434
| +46% | +$258K | ﹤0.01% | 3439 |
|
|
2019
Q3 | $834K | Buy |
33,507
+5,771
| +21% | +$158K | ﹤0.01% | 3432 |
|
|
2019
Q2 | $547K | Buy |
+27,736
| New | +$1.09M | ﹤0.01% | 3497 |
|
State Street's CKPT Position: Q2 2025 in Review
State Street sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 158,852 shares — an estimated $642K sold.
State Street first reported a position in CKPT in Q2 2019 and held it in 24 quarters. The position peaked at $2.68M in Q1 2021. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- State Street reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- State Street sold 158,852 Checkpoint Therapeutics shares in Q2 2025, an estimated $642K.
- State Street first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 24 quarters.
- State Street's Checkpoint Therapeutics position peaked at $2.68M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.